422545-95-7

Basic information

• Product Name: 2-Pyrrolidineethanamine,1-methyl-,(2S)-(9CI)
• Synonyms: 2-Pyrrolidineethanamine,1-methyl-,(2S)-(9CI);2-[(2S)-1-Methylpyrrolidin-2-yl]ethanamine;(S)-2-(1-methylpyrrolidin-2-yl)ethanamine;2-[(2S)-1-Methylpyrrolidin-2-yl]ethan-1-aMine;(S)-1-Methyl-2-pyrrolidineethanamine;(S)-2-(1-methylpyrrolidin-2-yl)ethan-1-amine
• CAS NO: 422545-95-7
• Molecular Formula: C₇H₁₆N₂
• Molecular Weight: 128.22
• Product Categories: AMINETERTIARY
• Mol File: 422545-95-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 152.7 °C at 760 mmHg
• Flash Point: 65 °C
• Appearance: /
• Density: 0.909 g/cm³
• Storage Temp.: 2-8°C(protect from light)
• PKA: 10.34±0.40(Predicted)
• CAS DataBase Reference: 2-Pyrrolidineethanamine,1-methyl-,(2S)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrrolidineethanamine,1-methyl-,(2S)-(9CI)(422545-95-7)
• EPA Substance Registry System: 2-Pyrrolidineethanamine,1-methyl-,(2S)-(9CI)(422545-95-7)

Safety Data

• Hazardous Substances Data: 422545-95-7(Hazardous Substances Data)

Usage

General Description

2-Pyrrolidineethanamine,1-methyl, (2S)-(9CI) is a chemical compound with the formula C6H13N. It is also known as (S)-N-Methyl-2-pyrrolidinylmethylamine and is a chiral amine that contains a pyrrolidine ring. 2-Pyrrolidineethanamine,1-methyl-,(2S)-(9CI) is commonly used as a building block in organic synthesis and pharmaceutical manufacturing. It has potential pharmacological activities and is used in the production of various drugs, including antiviral and antiparkinsonian medications. Additionally, it is also utilized as an intermediate in the synthesis of various fine chemicals.

Upstream product

• 67824-39-9 2-((2S)-1-methylpyrrolidin-2-yl)ethanenitrile 
• 51387-90-7 2-(2-AMINOETHYL)-1-METHYLPYRROLIDINE 
• 1332848-72-2 (-)-2-(2-aminoethyl)-1-methylpyrrolidine O,O'-di-p-toluoyl-D-tartaric acid salt 

Downstream Products

• 865311-47-3 quarfloxin 
• 865311-47-3 quarfloxacin 
• 1259499-69-8 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide 

Relevant articles and documents

PROCESS FOR THE PREPARATION OF 2-(CYCLOHEXYLMETHYL)-N-{2- [(2S)-1-METHYLPYRROLIDIN-2-YL]ETHYL}-1, 2, 3, 4- TETRAHYDROISOQUINOLINE-7-SULFONAMIDE

Industrially applicable process for preparing 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, and salts thereof.

NOVEL ALIPHATIC COMPOUND, METHOD OF SYNTHESIS, AND METHOD OF UTILIZATION

The present invention relates to aliphatic compounds of the formula I, or stereoisomers thereof, or their pharmaceutically acceptable salts: wherein A represents an optionally substituted CH3CnH(2n-2m)- (wherein n denotes an integer of 4 to 22, and m represents an unsaturation number which is an integer of 0 to 7), 1 represents an integer of 0 to 10, s represents 0 or 1, provided that when s is 0, p+q = 4 or 5, but when s is 1, p+q = 3 or 4, and in each case, either p or q is an integer of 1 or more, R represents an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and RA represents hydrogen or an alkyl group having 1 to 10 carbon atoms which may be straight-chain or branched-chain, and their use in suppression of platelet aggregation, in suppression of inflammation, and in prevention and treatment of circulatory diseases.